Clinolipid

DRUG2 trials

Sponsors

Baxter Healthcare Corporation

Conditions

Essential Fatty Acid Deficiency (EFAD)

Phase 4

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion

TerminatedNCT02476994

Baxter Healthcare CorporationEssential Fatty Acid Deficiency (EFAD)

Start: 2015-05-31End: 2016-10-31Updated: 2021-07-21

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

CompletedNCT04555044

Baxter Healthcare CorporationEssential Fatty Acid Deficiency (EFAD)

Start: 2021-01-22End: 2022-11-16Updated: 2023-12-27

Related Papers

Essential fatty acid deficiency, olive oil‐based intravenous lipid emulsion, and genetic polymorphisms: A pediatric randomized controlled trial

Journal of Pediatric Gastroenterology and Nutrition2025-05-252 citations